KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Gross Margin Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn 531.00
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -168.00
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn 449.00
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn 134.00
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -367.00
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn 129.00
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -1,698.00
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -714.00
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -367.00
Dec 31, 2025 45,915.00
Sep 30, 2025 -838.00
Jun 30, 2025 2,206.00
Mar 31, 2025 -1,140.00
Dec 31, 2024 -10,060.00
Sep 30, 2024 2,316.00
Jun 30, 2024 -1,349.00
Mar 31, 2024 2,384.00
Dec 31, 2023 -1,276.00
Sep 30, 2023 -2,615.00
Jun 30, 2023 -198.00
Mar 31, 2023 -362.00
Dec 31, 2022 -35,930.00
Sep 30, 2022 -491.00
Jun 30, 2022 -474.00
Mar 31, 2022 -2,497.00
Dec 31, 2021 6,653.00
Sep 30, 2021 -1,810.00
Jun 30, 2021 -2,475.00
Mar 31, 2021 -2,519.00
Dec 31, 2020 -2,471.00
Sep 30, 2020 543.00
Jun 30, 2020 -2,387.00
Mar 31, 2020 -540.00
Dec 31, 2019 -2,109.00
Sep 30, 2019 -35.00
Jun 30, 2019 103.00
Mar 31, 2019 1,937.00
Dec 31, 2018 -5,849.00
Sep 30, 2018 1,285.00
Jun 30, 2018 2,051.00
Mar 31, 2018 2,114.00
Dec 31, 2017 2,236.00
Sep 30, 2017 1,658.00
Jun 30, 2017 2,174.00
Mar 31, 2017 -1,877.00
Dec 31, 2016 -4,441.00
Sep 30, 2016 -166.00
Jun 30, 2016 -210.00
Mar 31, 2016 -1,905.00
Dec 31, 2015 12,757.00
Sep 30, 2015 -30.00
Jun 30, 2015 -294.00
Mar 31, 2015 -197.00
Dec 31, 2014 112.00
Sep 30, 2014 0.00
Jun 30, 2014 -638.00
Mar 31, 2014 1,520.00
Dec 31, 2013 348.00
Sep 30, 2013 -134.00
Jun 30, 2013 -1,708.00
Mar 31, 2013 -36.00
Dec 31, 2012 -10,897.00
Sep 30, 2012 -386.00
Jun 30, 2012 -1,656.00
Mar 31, 2012 -449.00